CTEV
NYSEClaritev Corporation
$21.67
-1.88 (-7.98%)
2026-05-22 00:00
Healthcare
Health Information Services
--
--
Short Interest (1 Year)
% of Volume Sold ShortMarket Cap
$470.2M
P/E Ratio
N/A
52W Low
52W High
$11.53
$73.68
Volume
134K
Analyst Rating
Hold
Target: $46
8 Analyst Ratings
Strong Buy
0
Buy
0
Hold
8
Sell
0
Price Target Range
Low: $40
Avg: $46
High: $57
About Claritev Corporation
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and r...
Employees
3,000
Website
claritev.com
Financial Highlights
Annual
Quarterly
| Year | Revenue | Op Margin | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2025 | $965.4M | 4.7% | -$284.3M | $246.9M |
| 2024 | $930.6M | -149.4% | -$1.65B | $225.7M |
| 2023 | $961.5M | 16.8% | -$91.7M | $280.6M |
| 2022 | $1.08B | -33.6% | -$572.9M | $462.1M |
| 2021 | $1.12B | 34.5% | $102.1M | $489.3M |
| 2026 Q1 | $244.7M | 2.7% | -$73.6M | -$1.9M |
| 2025 Q4 | $246.6M | 3.5% | -$80.6M | $96.2M |
| 2025 Q3 | $246.0M | 4.1% | -$69.8M | $56.1M |
| 2025 Q2 | $241.6M | 6.9% | -$62.6M | $85.9M |
| 2025 Q1 | $231.3M | 4.2% | -$71.3M | $8.8M |
| 2024 Q4 | $232.1M | -17.8% | -$138.0M | -$3.6M |
| 2024 Q3 | $230.5M | -146.7% | -$391.4M | $104.5M |
| 2024 Q2 | $233.5M | -224.4% | -$576.7M | $43.9M |